Scientists hunt for blood clue to bone damage in cancer
NCT ID NCT02800954
Summary
This study aimed to understand if a protein in the blood called M-CSF could be a useful marker for bone damage in multiple myeloma. Researchers compared M-CSF levels in three groups: people with multiple myeloma, people with a related but non-cancerous condition (MGUS), and healthy people. The goal was to see if higher protein levels were linked to bone problems like fractures or pain in myeloma patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH Beauvais
Beauvais, 60021, France
-
CHU Amiens
Amiens, 80054, France
-
Ch Saint Quentin
Saint-Quentin, 02321, France
Conditions
Explore the condition pages connected to this study.